Vontobel Holding
ABBV icon

Vontobel Holding’s AbbVie ABBV Stock Holding History

Vontobel Holding’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$105M Buy
401,527
+203,417
+103% +$52.1M 0.38% 61
2026
Q2 		$49.9M Buy
198,110
+27,196
+16% +$5.85M 0.16% 132
2026
Q1 		$37.2M Buy
170,914
+25,190
+17% +$5.59M 0.13% 151
2025
Q4 		$33.3M Buy
145,724
+2,988
+2% +$681K 0.1% 158
2025
Q3 		$33M Buy
142,736
+396
+0.3% +$80.6K 0.1% 145
2025
Q2 		$26.4M Buy
142,340
+7,900
+6% +$1.47M 0.08% 163
2025
Q1 		$28.2M Buy
134,440
+3,841
+3% +$747K 0.1% 138
2024
Q4 		$23.2M Sell
130,599
-4,079
-3% -$750K 0.08% 148
2024
Q3 		$26.6M Buy
134,678
+2,087
+2% +$390K 0.09% 145
2024
Q2 		$22.7M Sell
132,591
-35,099
-21% -$5.81M 0.07% 149
2024
Q1 		$30.5M Sell
167,690
-20,138
-11% -$3.47M 0.24% 107
2023
Q4 		$29.1M Sell
187,828
-2,895
-2% -$422K 0.24% 107
2023
Q3 		$28.4M Sell
190,723
-20,233
-10% -$2.97M 0.26% 98
2023
Q2 		$28.4M Sell
210,956
-91
-0% -$13.3K 0.25% 99
2023
Q1 		$33.6M Buy
211,047
+21,056
+11% +$3.22M 0.31% 86
2022
Q4 		$30.8M Sell
189,991
-15,931
-8% -$2.44M 0.31% 86
2022
Q3 		$27.6M Buy
205,922
+38,043
+23% +$5.46M 0.32% 81
2022
Q2 		$25.9M Sell
167,879
-7
-0% -$1.07K 0.28% 84
2022
Q1 		$27.5M Sell
167,886
-64,487
-28% -$9.37M 0.24% 97
2021
Q4 		$31.6M Sell
232,373
-27,381
-11% -$3.23M 0.26% 86
2021
Q3 		$28M Buy
259,754
+33,389
+15% +$3.82M 0.25% 90
2021
Q2 		$25.4M Sell
226,365
-8,146
-3% -$917K 0.22% 97
2021
Q1 		$25.4M Buy
234,511
+53,279
+29% +$5.7M 0.19% 78
2020
Q4 		$19.4M Buy
+181,232
New +$17.4M 0.13% 117

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Vontobel Holding's ABBV Position: Q3 2026 in Review

Vontobel Holding increased its AbbVie (ABBV) stake by 103% in Q3 2026, buying an estimated $52.1M and bringing the position to 401,527 shares worth $105M. The position accounts for 0.38% of the portfolio, ranked #61.

Vontobel Holding first reported a position in ABBV in Q4 2020 and has held it in 24 quarters since. 3,064 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Vontobel Holding held 401,527 shares of AbbVie worth $105M as of Q3 2026.
  • Vontobel Holding bought 203,417 AbbVie shares in Q3 2026, an estimated $52.1M.
  • AbbVie made up 0.38% of Vontobel Holding's portfolio in Q3 2026, its #61 holding.
  • Vontobel Holding first reported a position in AbbVie in Q4 2020 and has held it in 24 quarters since.
  • 3,064 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Vontobel Holding's 13F filing for Q3 2026, filed 16 Oct 2026.